InvestorsHub Logo
Followers 51
Posts 6706
Boards Moderated 0
Alias Born 01/17/2011

Re: None

Wednesday, 01/21/2015 6:22:21 PM

Wednesday, January 21, 2015 6:22:21 PM

Post# of 403222
25-40 approved drugs, pending drugs, development drugs, plus others in development with different partners--Non ART

Positive ART drug trials received and more fully expected in 8 billion dollar market

Further trials all expected to be positive

Numerous patents

Incredible leadership leading the company...attracting top talent from larger pharmas willing to come to a small company shows confidence.

No one can present any legitimate reason why Elite's ART doesn't work, won't work, won't be approved and because it is modular would represent a shift in the entire market. Elite has more products in development to prevent Abuse then anyone as far as I know

INCREDIBLY UNDERVALUED - No one is talking about the actual value and chances for real success....So when people talk about the transfer of wealth from the impatient to the patient...this is what that means.

Elite is highly likely to be successful and the returns if they are are many possible many many multiples of the current stock price....Simple

" A cynic is a man who knows the price of everything and the value of nothing". - Oscar Wilde

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News